Home / Produtos / Meloxinew® Gel
Meloxinew® Gel
Non-steroidal anti-inflammatory, preferential COX-2
Meloxinew® Gel
Non-steroidal anti-inflammatory, preferential COX-2
INDICATION

Meloxinew® Gel is indicated for treatment of inflammation and pain (acute or chronic) in cases involving soft and musculoskeletal tissues. Also indicated for post-surgery use.

MODE OF USE

To be used in equines by oral administration.

Administer at dose of 0,6 mg/Kg live weight, which is equivalent to 1 g of the product for every 100 Kg, at every 24 hours for 5 to 14 consecutive days. The plunger of the 35 g syringe is graded, and each dose mark (D) is sufficient to treat 500 Kg and every half dose, treats 250Kg live weight. Thus, a complete syringe contains 7 doses (D) for 500-Kg animals and 14 doses for 250-Kg animals.

Rotate the ring on the syringe plunger until the desired weight mark. Make sure the animal does not have any food in the mouth. Introduce the syringe in the interdental space and press the plunger, depositing the paste on the tongue in direction to the bottom of the mouth. After the application, raise the animal´s head for some seconds for adequate ingestion of the paste. The dosage may be changed according to the Veterinarian´s instructions.

COMPOSITION

EACH 100 g CONTAINS

Meloxicam 6,0 g
Excipients q.s. 100,0 g
PRESENTATION

Syringe with 35 g.

 

* Product considered DOPING according to the list of FEI (International Equestrian Federation). However, consult the specifi c regulations of the competition.

Sign up to receive news from

Name*
Phone*
CPF*
Birthday*
Select your profile*
CRMV*
CRMV State*
CRMV*
CRMV State*
Educational Institution*
Expected completion*
Subject of interest*

If you already have a registration, enter your email below!

E-mail *

Cadastre-se para receber novidades da

    Se você já tem cadastro, insira seu e-mail abaixo!

    E-mail *

    Bem-vindo a Vetnil®
    Usamos cookies para melhorar sua experiência.

    Nós guardamos informações técnicas e analíticas do seu acesso e navegação em nosso site.